# SEROQUEL XR
> **NDA022047** · New Drug Application · Sponsor: CHEPLAPHARM · Approved 2007-05-17
## Drug
- **FDA Application Number:** NDA022047
- **Application type:** New Drug Application
- **Brand name:** SEROQUEL XR
- **Generic name:** QUETIAPINE
- **Active ingredients:** QUETIAPINE FUMARATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHEPLAPHARM
- **Manufacturer:** AstraZeneca Pharmaceuticals LP
- **First approval:** 2007-05-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022047)
---
*AI Analytics · CC0 1.0*